If we determine our protocols are a good fit, you have a strong chance of seeing meaningful improvements in weight, appetite control, and metabolic markers such as blood sugar (A1C) and waist circumference over time
During the COVID-19 pandemic, tight glycaemic control and management of cardiovascular risk factors are crucial for patients with diabetes mellitus
Considerations: Requires medical care and is not appropriate for everyone, especially those without diabetes or other medical issues
To put that in perspective, thats roughly 1-2 people out of every 100
Once enrolled, adult patients in the EMPA-REG OUTCOME, EMPEROR-Reduced, EMPEROR-Preserved, and EMPA-KIDNEY trials were not required to discontinue therapy for worsening of eGFR to less than 20 mL/min/1.73 m2 or initiation of dialysis [see Clinical Studies (14.3, 14.4, 14.5)]
This site may be less practical for self-injection due to the angle required and limited visibility